-
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL
de Boer, J. W., Keijzer, K., van Dorp, S., Mutsaers, P. G. N. J., Niezink, A. G. H., van Doesum, J. A., Serroukh, Y. I. M., Muntendam, L. W., Pulles, A. E., Kret, E. J., Sijs-Szabo, A., Oomen, J., Demandt, A. M. P., Stevens, W. B. C., Kuipers, M. T. & the Dutch CAR-T Tumorboard Consortium, 11 Nov 2025, In: Blood. 9, 21, p. 5641-5650 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe
Broussais, F., Pennings, E., Bolanos, N., Warwick, L., Doeswijk, R., Quinonez, G., Lebeda, A., da Silva, M. G., Leppä, S., Lenz, G., Cottereau, A.-S. G., Fox, C., Lopez-Guillermo, A., Illidge, T., Jurczak, W., Eich, H., Aurer, I., Trneny, M., Rosenwald, A. A. & Davies, A. & 7 others, , 1 Sept 2025, In: HemaSphere. 9, 9, e70204.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands
Pennings, E. R. A., Durmaz, M. J., Visser, O., Posthuma, E. F. M., Issa, D. E., Chamuleau, M. E. D., Lugtenburg, P. J., Kersten, M. J. & Dinmohamed, A. G., 1 Dec 2024, In: Blood Cancer Journal. 14, 1, 3.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications
